Covid-19: why vaccine mistrust is growing | The Economist

World News

Covid-19: why vaccine mistrust is growing | The Economist

A vaccine for covid-19 could be rolled out before the end of the year. But a worrying rise in mistrust of vaccines threatens its effectiveness. Film supported by Mishcon de Reya. Now & Next is a series from The Economist Films:

Further content:

Find The Economist’s most recent coverage of covid-19 here:

Sign up to The Economist’s daily newsletter to keep up to date with our latest covid-19 analysis:

The immense promise of the new covid-19 vaccine, and the challenges still to come:

Why an effective covid-19 vaccine is a turning point in the pandemic:

Read more about Pfizer’s and BioNTech’s vaccine:

A second, better, vaccine against covid-19 arrives—read about Moderna’s vaccine:

Rich countries have grabbed half of projected covid-19 vaccine supply:

Daily chart: One in three people want preferential access to a covid-19 vaccine:

How pandemic fears are boosting demand for trustworthy news:

Super fast tests for covid-19 are coming:

How the quest for a vaccine could restore faith in big pharma: